ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Lidocaine Aguettant 10 mg/ml et 20 mg/ml:Aguettant Suisse SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
N01BB02 - LidocaineATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N01 - Anesthetics
 

No DDDs have been established in this group because the doses used vary substantially.

N01B - Anesthetics, Local

Local anesthetics in this context mean anesthetics which only affect a local area as opposed to general anesthetics affecting the entire body.
Creams, plasters and sprays containing e.g. lidocaine or prilocaine used as anesthetics/analgesics or in premature ejaculation are classified in N01BB.
Local anesthetics for dermatological use such as treatment of pruritus, minor burns and insect stings are classified in D04AB - Anesthetics for topical use.
Antihemorrhoidals containing anesthetics, see C05AD - Local anesthetics.
Stomatologicals with anesthetics, see A01AD.
Combinations of corticosteroids and anesthetics for oral local treatment, see A01AC.
Throat preparations with anesthetics, see R02AD - Anesthetics, local.
Ophthalmological anesthetics, see S01HA.
Combinations with e.g. epinephrine are classified at separate 5th levels by using the 50-series.

N01BB - Amides

Lidocaine injections used as antiarrhythmics are classified in C01BB.

N01BB02 - Lidocaine
2024 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home